Closure of patent foramen ovale versus medical therapy after cryptogenic stroke

John D Carroll1, Jeffrey L Saver, David E Thaler

  • 1University of Colorado Denver/University of Colorado Hospital, Aurora, CO 80045, USA. john.carroll@ucdenver.edu

Insights

Closure of a patent foramen ovale (PFO) did not show significant benefit in preventing recurrent ischemic stroke in the primary analysis. However, PFO closure proved superior to medical therapy alone in secondary analyses for cryptogenic stroke patients.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Devices

Background:

  • Cryptogenic stroke affects patients without a clear cause.
  • Patent foramen ovale (PFO) is a potential, yet unproven, cause of cryptogenic stroke.
  • The efficacy of PFO closure versus medical therapy for stroke prevention remains uncertain.

Purpose of the Study:

  • To evaluate if PFO closure is superior to medical therapy alone in preventing recurrent ischemic stroke.
  • To assess the safety and efficacy in patients aged 18-60 with cryptogenic stroke.

Main Methods:

  • A prospective, multicenter, randomized, event-driven trial.
  • 980 patients were randomized 1:1 to medical therapy alone or PFO closure.
  • Primary results analyzed upon reaching 25 primary endpoint events.

Main Results:

  • In the intention-to-treat analysis, PFO closure did not significantly reduce recurrent stroke (HR 0.49, P=0.08).
  • Per-protocol (HR 0.37, P=0.03) and as-treated (HR 0.27, P=0.007) analyses showed significant stroke reduction with PFO closure.
  • Adverse events were similar between groups; procedure-related events were low (4.2%).

Conclusions:

  • PFO closure showed no significant benefit in the primary intention-to-treat analysis for cryptogenic stroke.
  • However, PFO closure demonstrated superiority in per-protocol and as-treated analyses.
  • PFO closure is associated with a low rate of risks when compared to medical therapy alone.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...